← Search

Excel · study · 2026

Tumor-Specific SVH-v2 Isoform Generated by PUF60 Promotes Lung Adenocarcinoma Progression by Driving Peripheral Mitochondrial Fission via FIS1 Mislocalization

Listed in NCBI GEO

Aberrant alternative splicing (AS) events are pervasive in tumor progression.

Description

SVH, also known as ARMC10, has multiple transcript variants and participates in the regulation of mitochondrial dynamics. SVH has been implicated in the progression of various cancers, but its role in lung adenocarcinoma (LUAD) remains unknown.

Here, SVH is found to be significantly upregulated in LUAD and associated with a poorer prognosis. Two isoforms, SVH-v1 and SVH-v2, exhibit predominant expressions in pulmonary tissues. Isoform-specific overexpression and depletion assays in cellular and murine models indicate that SVH-v2, rather than SVH-v1, promotes LUAD cell proliferation and tumor growth.

Read the rest (2 more)

Integrative transcriptomic and proteomic analyses reveal that the splicing factor PUF60 facilitates exon 2 skipping in SVH pre-mRNA, which leads to the generation of SVH-v2. Mechanistically, SVH-v2 induces the mislocalization of the mitochondrial fission factor FIS1 to the peripheral mitochondrial membrane, resulting in pathological mitochondrial peripheral fission. In contrast, SVH-v1 mediates non-oncogenic mitochondrial midzone fission.

Importantly, mitochondrial peripheral fission can further promote glycolytic reprogramming of LUAD cells. Disruption of the PUF60–SVH interaction or deletion of the FIS1 TPR domain effectively restores normal mitochondrial dynamics and attenuates tumorigenic phenotypes in cell lines, xenograft models, and patient-derived LUAD organoids. Overall, these findings demonstrate the functional differences and underlying mechanisms of SVH isoforms in LUAD tumorigenesis, highlighting a potential therapeutic target for LUAD.

Links

Where it is published

Documentation and papers

Topics

From keywords
Life Sciences
Inferred from text
Cancer 65%
Provenance · 1 source records, 8 field assertions
SourceKeyLast seenRaw
NCBI GEOGSE30694114 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[disease].local:disease:cancerenrichment · NCBI GEOkeyword-concept-rules@1.0.0title+description (65%)
concepts[field].local:field:life-sciencesmapping · NCBI GEOconnector:ncbi_geo@1.0.0
concepts[method].geo_series_type:expression-profiling-by-high-throughput-sequencingsource · NCBI GEOconnector:ncbi_geo@1.0.0/gdstype
concepts[organism].NCBITaxon:9606source · NCBI GEOconnector:ncbi_geo@1.0.0/taxon
descriptionsource · NCBI GEOconnector:ncbi_geo@1.0.0/summary
publication_datesource · NCBI GEOconnector:ncbi_geo@1.0.0
titlesource · NCBI GEOconnector:ncbi_geo@1.0.0/title